Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice
about
Temperament type specific metabolite profiles of the prefrontal cortex and serum in cattleLipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and QuantificationSite-specific and time-dependent activation of the endocannabinoid system after transection of long-range projectionsPerinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats.Mass spectrometry imaging of biomarker lipids for phagocytosis and signalling during focal cerebral ischaemiaCannabinoids in experimental stroke: a systematic review and meta-analysis.Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage.Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for strokeChanges in N-acylethanolamine Pathway Related Metabolites in a Rat Model of Cerebral Ischemia/Reperfusion.Accumulation of N-Acylphosphatidylserines and N-Acylserines in the Frontal Cortex in SchizophreniaFeeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodentsBrain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.Role of cannabinoids and endocannabinoids in cerebral ischemia.Identification by nuclear magnetic resonance spectroscopy of an active-site hydrogen-bond network in human monoacylglycerol lipase (hMGL): implications for hMGL dynamics, pharmacological inhibition, and catalytic mechanism.Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.Endocannabinoids and nutrition.Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death.Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury.Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor.Pitfalls in the sample preparation and analysis of N-acylethanolamines.Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats.The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.Nicotine-induced neuroprotection against ischemic injury involves activation of endocannabinoid system in rats.Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential Target to Prevent Alcohol-Induced Neurodegeneration.Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke.Octadecylpropyl Sulfamide Reduces Neurodegeneration and Restores the Memory Deficits Induced by Hypoxia-Ischemia in Mice.Membrane depolarization and aberrant lipid distributions in the neonatal rat brain following hypoxic-ischaemic insult.
P2860
Q21090552-420CFBD0-3093-4ABF-B306-F11519473F37Q26769959-C8E0AFE6-5198-4E95-8C93-55B54E8B5904Q27306768-7DB2F869-5B24-4B5A-86F0-2600AA65F8B7Q27322965-A5D7674B-B2B5-454D-B0BE-6AE0CE77786FQ28397015-6836AD61-E703-4C1D-BD06-41CAE17C36E7Q34452972-00C7C733-D382-4EC2-B759-F7EE0EE41586Q34531690-FA23CE3E-75B2-455D-B92A-6695F7F6A383Q34673425-28EE8710-5F8C-4B78-8EBE-29E81BF2DD0DQ35688321-F781675D-DCFF-44C9-B0C3-80708C2D9AE5Q35776132-AB90DFCF-14AF-4981-8AA8-95E5D9E961E1Q35893930-2058460F-958A-49AD-8D45-4787AE05A156Q36759329-DF74C643-1712-4A69-AC93-F8B735B47D9EQ36967863-77674106-F274-40D0-BD44-8327A8181F3FQ36971343-BAE2B58D-B0F7-4000-95C9-1399944F70ABQ37082410-49C4FD75-4356-4479-AC3C-F9EDF38C65BFQ37143596-41F3F59C-6C22-4863-8603-7FB99E84D6AAQ37349953-1B735D12-9BE6-4784-96F4-DBC8D0735A3DQ37352175-6809E953-C61A-4BC1-8DE7-CC6CC2315693Q37752096-E9408895-BDC6-443C-A2C1-3106F68FC016Q37793366-C4EB732A-5017-460F-A1E6-9EBBCD4F8264Q37905540-41AABE6C-18F7-4856-B67E-971C989A4D19Q38026790-B62B6642-9D00-4D23-AFE9-1F2F18B88DE5Q38563981-275F36BE-ECDC-4794-ACEC-01B8EB519343Q39809216-95B5E9D8-0233-44AD-A3EE-E26B83CC79B8Q39875770-71B73920-F48B-4BA0-BFE6-15F41CD7AD6AQ40877659-11CE97AA-0FF1-43C1-ABBF-3C5676EE5BE5Q40961956-C4196ECA-3FFA-4F7E-B0A5-1E44429A9829Q44793980-F4127761-E4B7-46AB-A2B8-FE747E7C8885Q47944859-153115A3-FC5C-47D2-835E-C513AC9A6D16Q50026271-02BEC871-E760-44BA-9855-39E772870514Q55100647-5387ACF1-0271-4234-9EEF-355894A608C6Q55155924-324D5BCE-029A-4C20-A2A5-78E3A592B32C
P2860
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2007
@uk
name
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@en
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@nl
type
label
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@en
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@nl
prefLabel
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@en
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@nl
P2093
P2860
P50
P1476
Changes in brain levels of N-a ...... ocal cerebral ischemia in mice
@en
P2093
Andreas Artmann
Gitte Petersen
Michael Meldgaard
Steen H Hansen
P2860
P304
P356
10.1111/J.1471-4159.2007.04892.X
P407
P50
P577
2007-12-01T00:00:00Z